Long-term Effects of COVID-19 on Sleep Patterns.

To examine the long-term impact of Coronavirus Disease 2019 (COVID-19) on sleep patterns and prevalence of sleep disorders and to increase public health awareness of long COVID. MATERIAL AND Using the centralized Massachusetts General Brigham Research Patient Data Registry (RPDR), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive patients were surveyed about their sleep patterns before and after the viral infection. Information related to co-morbid conditions and medications was obtained through chart review.

Associations Between Insomnia and Obstructive Sleep Apnea with Nutritional Intake After Involuntary Job Loss.

Objectives: Involuntary job loss is a stressful life event that can result in changes in nutritional intake. Both insomnia and obstructive sleep apnea (OSA) also are associated with alterations in dietary intake, but the extent to which this occurs in those who have experienced involuntary job loss is unclear. This study assessed nutritional intake in recently unemployed persons with insomnia and obstructive sleep apnea in comparison to those without a sleep disorder.

Quantifying the impact of the Philips recall on patients with sleep apnea and clinicians.

Study Objectives: Philips Respironics issued a voluntary recall of positive airway pressure devices used to treat obstructive sleep apnea in June 2021. We surveyed sleep medicine clinicians from the American Academy of Sleep Medicine membership to assess the impact of the recall on clinicians and patients.

Methods: One hundred thirty-six clinicians participated between June 2022 and November 2022.

Application of artificial intelligence in the diagnosis of sleep apnea.

Study Objectives: Machine learning (ML) models have been employed in the setting of sleep disorders. This review aims to summarize the existing data about the role of ML techniques in the diagnosis, classification, and treatment of sleep-related breathing disorders.

Methods: A systematic search in Medline, EMBASE, and Cochrane databases through January 2022 was performed.

NREM Parasomnias: Retrospective Analysis of Treatment Approaches and Comorbidities.

The aim of this retrospective analysis is to determine the most frequently prescribed medications for the treatment of NREM parasomnias and evaluate reported outcomes. We performed a retrospective chart review of all patients with NREM parasomnia diagnosed within Brigham and Women's Hospital (BWH) clinics examining the date of diagnosis, date of starting therapy, comorbidities, type of medication prescribed, and the reported change in symptoms or side effects at follow-up visits. From 2012 to 2019, 110 patients (59 females, 51 male) at BWH clinics received a diagnosis of NREM parasomnia, including sleepwalking and night terrors.